Global and China Dry Eye Syndrome Drugs Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Antibiotic Drops
1.2.3 Hormone Drops
1.2.4 Artificial Tears
1.3 Market by Application
1.3.1 Global Dry Eye Syndrome Drugs Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Dry Eye Syndrome Drugs Market Perspective (2015-2026)
2.2 Global Dry Eye Syndrome Drugs Growth Trends by Regions
2.2.1 Dry Eye Syndrome Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Dry Eye Syndrome Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Dry Eye Syndrome Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dry Eye Syndrome Drugs Players by Market Size
3.1.1 Global Top Dry Eye Syndrome Drugs Players by Revenue (2015-2020)
3.1.2 Global Dry Eye Syndrome Drugs Revenue Market Share by Players (2015-2020)
3.2 Global Dry Eye Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dry Eye Syndrome Drugs Revenue
3.4 Global Dry Eye Syndrome Drugs Market Concentration Ratio
3.4.1 Global Dry Eye Syndrome Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dry Eye Syndrome Drugs Revenue in 2019
3.5 Key Players Dry Eye Syndrome Drugs Area Served
3.6 Key Players Dry Eye Syndrome Drugs Product Solution and Service
3.7 Date of Enter into Dry Eye Syndrome Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dry Eye Syndrome Drugs Breakdown Data by Type (2015-2026)
4.1 Global Dry Eye Syndrome Drugs Historic Market Size by Type (2015-2020)
4.2 Global Dry Eye Syndrome Drugs Forecasted Market Size by Type (2021-2026)
5 Dry Eye Syndrome Drugs Breakdown Data by Application (2015-2026)
5.1 Global Dry Eye Syndrome Drugs Historic Market Size by Application (2015-2020)
5.2 Global Dry Eye Syndrome Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Dry Eye Syndrome Drugs Market Size (2015-2026)
6.2 North America Dry Eye Syndrome Drugs Market Size by Type (2015-2020)
6.3 North America Dry Eye Syndrome Drugs Market Size by Application (2015-2020)
6.4 North America Dry Eye Syndrome Drugs Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Dry Eye Syndrome Drugs Market Size (2015-2026)
7.2 Europe Dry Eye Syndrome Drugs Market Size by Type (2015-2020)
7.3 Europe Dry Eye Syndrome Drugs Market Size by Application (2015-2020)
7.4 Europe Dry Eye Syndrome Drugs Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Dry Eye Syndrome Drugs Market Size (2015-2026)
8.2 China Dry Eye Syndrome Drugs Market Size by Type (2015-2020)
8.3 China Dry Eye Syndrome Drugs Market Size by Application (2015-2020)
8.4 China Dry Eye Syndrome Drugs Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Dry Eye Syndrome Drugs Market Size (2015-2026)
9.2 Japan Dry Eye Syndrome Drugs Market Size by Type (2015-2020)
9.3 Japan Dry Eye Syndrome Drugs Market Size by Application (2015-2020)
9.4 Japan Dry Eye Syndrome Drugs Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Dry Eye Syndrome Drugs Market Size (2015-2026)
10.2 Southeast Asia Dry Eye Syndrome Drugs Market Size by Type (2015-2020)
10.3 Southeast Asia Dry Eye Syndrome Drugs Market Size by Application (2015-2020)
10.4 Southeast Asia Dry Eye Syndrome Drugs Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Dry Eye Syndrome Drugs Introduction
11.1.4 Allergan Revenue in Dry Eye Syndrome Drugs Business (2015-2020))
11.1.5 Allergan Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Dry Eye Syndrome Drugs Introduction
11.2.4 Novartis Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
11.2.5 Novartis Recent Development
11.3 Santen
11.3.1 Santen Company Details
11.3.2 Santen Business Overview
11.3.3 Santen Dry Eye Syndrome Drugs Introduction
11.3.4 Santen Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
11.3.5 Santen Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Dry Eye Syndrome Drugs Introduction
11.4.4 Takeda Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
11.4.5 Takeda Recent Development
11.5 Otsuka
11.5.1 Otsuka Company Details
11.5.2 Otsuka Business Overview
11.5.3 Otsuka Dry Eye Syndrome Drugs Introduction
11.5.4 Otsuka Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
11.5.5 Otsuka Recent Development
11.6 Eyegate Pharma
11.6.1 Eyegate Pharma Company Details
11.6.2 Eyegate Pharma Business Overview
11.6.3 Eyegate Pharma Dry Eye Syndrome Drugs Introduction
11.6.4 Eyegate Pharma Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
11.6.5 Eyegate Pharma Recent Development
11.7 Can-Fite BioPharma
11.7.1 Can-Fite BioPharma Company Details
11.7.2 Can-Fite BioPharma Business Overview
11.7.3 Can-Fite BioPharma Dry Eye Syndrome Drugs Introduction
11.7.4 Can-Fite BioPharma Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
11.7.5 Can-Fite BioPharma Recent Development
11.8 Bausch and Lomb
11.8.1 Bausch and Lomb Company Details
11.8.2 Bausch and Lomb Business Overview
11.8.3 Bausch and Lomb Dry Eye Syndrome Drugs Introduction
11.8.4 Bausch and Lomb Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
11.8.5 Bausch and Lomb Recent Development
11.9 Auven Therapeutics (Celtic)
11.9.1 Auven Therapeutics (Celtic) Company Details
11.9.2 Auven Therapeutics (Celtic) Business Overview
11.9.3 Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Introduction
11.9.4 Auven Therapeutics (Celtic) Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
11.9.5 Auven Therapeutics (Celtic) Recent Development
11.10 Bridge Pharma
11.10.1 Bridge Pharma Company Details
11.10.2 Bridge Pharma Business Overview
11.10.3 Bridge Pharma Dry Eye Syndrome Drugs Introduction
11.10.4 Bridge Pharma Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
11.10.5 Bridge Pharma Recent Development
11.11 Cellzome
10.11.1 Cellzome Company Details
10.11.2 Cellzome Business Overview
10.11.3 Cellzome Dry Eye Syndrome Drugs Introduction
10.11.4 Cellzome Revenue in Dry Eye Syndrome Drugs Business (2015-2020)
10.11.5 Cellzome Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Antibiotic Drops
Table 4. Key Players of Hormone Drops
Table 5. Key Players of Artificial Tears
Table 6. Global Dry Eye Syndrome Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Dry Eye Syndrome Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Dry Eye Syndrome Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Dry Eye Syndrome Drugs Market Share by Regions (2015-2020)
Table 10. Global Dry Eye Syndrome Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Dry Eye Syndrome Drugs Market Share by Regions (2021-2026)
Table 12. Dry Eye Syndrome Drugs Market Market Trends
Table 13. Dry Eye Syndrome Drugs Market Drivers
Table 14. Dry Eye Syndrome Drugs Market Challenges
Table 15. Dry Eye Syndrome Drugs Market Restraints
Table 16. Global Dry Eye Syndrome Drugs Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Dry Eye Syndrome Drugs Market Share by Players (2015-2020)
Table 18. Global Top Dry Eye Syndrome Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Eye Syndrome Drugs as of 2019)
Table 19. Global Dry Eye Syndrome Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dry Eye Syndrome Drugs Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Dry Eye Syndrome Drugs Market Size Share by Type (2015-2020)
Table 25. Global Dry Eye Syndrome Drugs Revenue Market Share by Type (2021-2026)
Table 26. Global Dry Eye Syndrome Drugs Market Size Share by Application (2015-2020)
Table 27. Global Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Dry Eye Syndrome Drugs Market Size Share by Application (2021-2026)
Table 29. North America Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Dry Eye Syndrome Drugs Market Share by Type (2015-2020)
Table 31. North America Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Dry Eye Syndrome Drugs Market Share by Application (2015-2020)
Table 33. North America Dry Eye Syndrome Drugs Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Dry Eye Syndrome Drugs Market Share by Country (2015-2020)
Table 35. Europe Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Dry Eye Syndrome Drugs Market Share by Type (2015-2020)
Table 37. Europe Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Dry Eye Syndrome Drugs Market Share by Application (2015-2020)
Table 39. Europe Dry Eye Syndrome Drugs Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Dry Eye Syndrome Drugs Market Share by Country (2015-2020)
Table 41. China Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (US$ Million)
Table 42. China Dry Eye Syndrome Drugs Market Share by Type (2015-2020)
Table 43. China Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (US$ Million)
Table 44. China Dry Eye Syndrome Drugs Market Share by Application (2015-2020)
Table 45. China Dry Eye Syndrome Drugs Market Size by Region (US$ Million) (2015-2020)
Table 46. China Dry Eye Syndrome Drugs Market Share by Region (2015-2020)
Table 47. Japan Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Dry Eye Syndrome Drugs Market Share by Type (2015-2020)
Table 49. Japan Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Dry Eye Syndrome Drugs Market Share by Application (2015-2020)
Table 51. Japan Dry Eye Syndrome Drugs Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Dry Eye Syndrome Drugs Market Share by Country (2015-2020)
Table 53. Southeast Asia Dry Eye Syndrome Drugs Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Dry Eye Syndrome Drugs Market Share by Type (2015-2020)
Table 55. Southeast Asia Dry Eye Syndrome Drugs Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Dry Eye Syndrome Drugs Market Share by Application (2015-2020)
Table 57. Southeast Asia Dry Eye Syndrome Drugs Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Dry Eye Syndrome Drugs Market Share by Country (2015-2020)
Table 59. Allergan Company Details
Table 60. Allergan Business Overview
Table 61. Allergan Product
Table 62. Allergan Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (US$ Million)
Table 63. Allergan Recent Development
Table 64. Novartis Company Details
Table 65. Novartis Business Overview
Table 66. Novartis Product
Table 67. Novartis Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (US$ Million)
Table 68. Novartis Recent Development
Table 69. Santen Company Details
Table 70. Santen Business Overview
Table 71. Santen Product
Table 72. Santen Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (US$ Million)
Table 73. Santen Recent Development
Table 74. Takeda Company Details
Table 75. Takeda Business Overview
Table 76. Takeda Product
Table 77. Takeda Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (US$ Million)
Table 78. Takeda Recent Development
Table 79. Otsuka Company Details
Table 80. Otsuka Business Overview
Table 81. Otsuka Product
Table 82. Otsuka Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (US$ Million)
Table 83. Otsuka Recent Development
Table 84. Eyegate Pharma Company Details
Table 85. Eyegate Pharma Business Overview
Table 86. Eyegate Pharma Product
Table 87. Eyegate Pharma Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (US$ Million)
Table 88. Eyegate Pharma Recent Development
Table 89. Can-Fite BioPharma Company Details
Table 90. Can-Fite BioPharma Business Overview
Table 91. Can-Fite BioPharma Product
Table 92. Can-Fite BioPharma Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (US$ Million)
Table 93. Can-Fite BioPharma Recent Development
Table 94. Bausch and Lomb Business Overview
Table 95. Bausch and Lomb Product
Table 96. Bausch and Lomb Company Details
Table 97. Bausch and Lomb Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (US$ Million)
Table 98. Bausch and Lomb Recent Development
Table 99. Auven Therapeutics (Celtic) Company Details
Table 100. Auven Therapeutics (Celtic) Business Overview
Table 101. Auven Therapeutics (Celtic) Product
Table 102. Auven Therapeutics (Celtic) Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (US$ Million)
Table 103. Auven Therapeutics (Celtic) Recent Development
Table 104. Bridge Pharma Company Details
Table 105. Bridge Pharma Business Overview
Table 106. Bridge Pharma Product
Table 107. Bridge Pharma Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (US$ Million)
Table 108. Bridge Pharma Recent Development
Table 109. Cellzome Company Details
Table 110. Cellzome Business Overview
Table 111. Cellzome Product
Table 112. Cellzome Revenue in Dry Eye Syndrome Drugs Business (2015-2020) (US$ Million)
Table 113. Cellzome Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Dry Eye Syndrome Drugs Market Share by Type: 2020 VS 2026
Figure 2. Antibiotic Drops Features
Figure 3. Hormone Drops Features
Figure 4. Artificial Tears Features
Figure 5. Global Dry Eye Syndrome Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Household Use Case Studies
Figure 9. Dry Eye Syndrome Drugs Report Years Considered
Figure 10. Global Dry Eye Syndrome Drugs Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Dry Eye Syndrome Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Dry Eye Syndrome Drugs Market Share by Regions (2021-2026)
Figure 13. Global Dry Eye Syndrome Drugs Market Share by Players in 2019
Figure 14. Global Top Dry Eye Syndrome Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Eye Syndrome Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Dry Eye Syndrome Drugs Revenue in 2019
Figure 16. North America Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Dry Eye Syndrome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Allergan Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 44. Novartis Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 45. Santen Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 46. Takeda Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 47. Otsuka Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 48. Eyegate Pharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 49. Can-Fite BioPharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 50. Bausch and Lomb Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 51. Auven Therapeutics (Celtic) Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 52. Bridge Pharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 53. Cellzome Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed